Nobuyuki Katakami, Hirohito Tada, Tetsuya Mitsudomi, Shinzoh Kudoh, Hiroshi Senba, Kaoru Matsui, Hideo Saka, Takayasu Kurata, Yasumasa Nishimura and Masahiro Fukuoka A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903) Cancer 118
Version of Record online: 6 JUN 2012 | DOI: 10.1002/cncr.26689
The addition of radiotherapy to induction chemotherapy conferred better local control without adding significant adverse events in patients with stage IIIA (N2) nonsmall cell lung cancer. Tumor downstaging is important for prolonging overall survival.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field